Medite Cancer Diagnostics IncOver The Counter Market:MDIT
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medite Cancer Diagnostics Inc | 8.7K | 0.0x | --- |
Viveve Medical Inc | 2.1K | 0.0x | --- |
HTG Molecular Diagnostics Inc | 3.3K | 0.0x | --- |
G Medical Innovations Holdings Ltd | 489.3K | 0.0x | --- |
Arypsa Inc | 30.0 | 0.0x | --- |
Avinger Inc | 6.7M | -0.1x | --- |
Company Information
MEDITE Cancer Diagnostics, Inc. (MEDITE) is a medical technology company specialized in the development, manufacturing, and marketing of premium medical devices, consumables and molecular biomarkers for detection, risk assessment and diagnosis of cancerous and precancerous conditions and related diseases. The Company also develops, manufactures, markets, and sells MEDITE branded products (instruments and consumables), in the areas of histology and cytology. The Company has a distribution network to over 80 countries and a range of products for anatomic pathology, histology and cytology laboratories available for sale. The Company’s subsidiaries consist of MEDITE Enterprise, Inc., MEDITE GmbH, Burgdorf, Germany and MEDITE Lab Solutions Inc.
Contact Information
- Headquarters
- 414 N Orleans St Ste 502CHICAGO, IL, United States 60654-4498
- Phone
- 407-849-0290
- Fax
- 312-222-9580
Executives
- Independent Chairman of the Board
- William Lewis
- Chief Operating Officer
- Michaela Ott
- Chief Marketing and Business Development Officer
- Jeff Rencher
- Director
- Gregory Fortunoff
- Independent Director
- John Abeles
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.7K |
|---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 86.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.15 |
Book Value | $0.20 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -49.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
